cream, candy, and bread, is an important pathogenic factor for hepatic steatosis. [3, 4] High-fructose flux leads to enhanced hepatic triglyceride (TG) accumulation, which plays a central role in the emergence of NAFLD. [5] [6] [7] [8] Nevertheless, the pathophysiology underlying this process is poorly understood. Some studies have shown that endoplasmic reticulum stress (ERS) signaling pathways contribute to the development of insulin resistance and hepatic steatosis in NAFLD. [9] [10] [11] [12] X-box binding protein-1 (XBP-1) is a major transcription regulator of the unfolded protein response (UPR), mediating adaptation to ERS. [13] Here, we hypothesized that XBP-1 plays a role in the process of fructose-stimulated lipogenesis in HepG2 cells.
Hepatic steatosis has been associated with fructose, a food additive, because excessive consumption of fructose can increase hepatic lipid accumulation. [14] Fatty acids come from three sources: (1) lipolysis of TGs stored in adipose tissue, (2) uptake of dietary fatty acids from the intestinal tract, and (3) de novo lipogenesis (newly synthesized from glucose) in the liver, the last of which accounts for about 20-30% of all fatty acids in hepatocytes. [15] Previous studies in rodents have shown that fructose can facilitate de novo lipogenesis. [16] [17] [18] Feeding rats with fructose increased hepatic levels of upstream regulators of de novo lipogenesis (i.e., sterol regulatory element-binding protein 1c and carbohydrate response element-binding protein [ChREBP] ) and key lipogenic enzymes (i.e., fatty acid synthase [FAS] , acetyl-CoA carboxylase [ACC] , and stearoyl-CoA desaturase-1 [SCD-1]). To verify these findings at a cellular level, in the present study, we incubated HepG2 cells with fructose or palmitic acid (PA) to investigate their effects on different sources of accumulated lipid.
ERS refers to an accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) lumen under conditions of impaired function, leading to an adaptive signaling response originating in the ER, namely the UPR. [13, 19] Three pathways are involved in ERS: (1) the inositol-requiring enzyme-1 (IRE-1)/XBP-1 pathway, (2) the protein kinase R-like ER kinase (PERK)/eukaryotic translation initiation factor-2α (eIF-2α) pathway, and (3) the activating transcription factor-6 pathway. [13] Recent studies have demonstrated that ERS is associated with the initiation and progression of many diseases, such as metabolic dyslipidemia, insulin resistance, NAFLD, cardiovascular disease, and neurodegenerative disease. [20] Some studies have reported that misfolded proteins alter ER homeostasis, creating a lipotoxic environment within hepatocytes, [21] but other studies have demonstrated that the lipotoxic environment of NAFLD directly influences ER homeostasis and ERS activation. [22] [23] [24] Thus, a link between ERS and lipid accumulation has been proposed, but the exact nature of the causal relationship between ERS and fatty acid synthesis remains unknown. In this study, we identified the factors associated with de novo lipogenesis after culturing HepG2 cells with: (1) high fructose, (2) high fructose followed by the ERS inhibitor tauroursodeoxycholic acid (TUDCA), or (3) the ERS inducer thapsigargin. XBP-1, also known as cAMP-response element-binding protein, belongs to a family of basic leucine zipper-containing proteins and can be found in two forms: unspliced XBP-1 (XBP-1u) and spliced XBP-1 (XBP-1s). XBP-1 is normally kept in its inactive form, but under ERS, the endoRNase domain of IRE-1 splices the mRNA of downstream sensor XBP-1, removing a 26-bp segment from the full-length XBP1 mRNA that generates a translational frameshift, leading to the expression of the active protein XBP-1s. [25] [26] [27] XBP-1s binds to intranuclear mRNA directly to regulate protein transcription, thereby affecting subsequent physiological activities. [28, 29] Lee et al.'s study [30] showed for the first time that XBP-1 regulates hepatic lipid metabolism, because XBP1-knockout mice manifested hypotriglyceridemia and hypocholesterolemia. On the basis of these observations, we propose that XBP-1 serves as a key conduit for ERS-induced hepatic lipid accumulation and steatosis in response to a high-fructose stimulus. Thus, in the present study, we investigated the expression of the transcription factor XBP-1 in the human HepG2 cell line after stimulation of cells with high fructose, and the regulatory effects of XBP-1 on de novo lipogenesis in the initial stages of NAFLD by evaluating the expression of key enzymes involved in lipogenesis. 
Methods

Reagents and chemicals
Determination of triglyceride levels in HepG2 cells
After the different treatments described above, HepG2 cells were collected to wash twice with phosphate-buffered saline (PBS) and then treated with radioimmunoprecipitation (RIPA) buffer for 30 min on ice. Samples were centrifuged at 13,000 ×g for 20 min at 4°C for getting the supernatant. The concentration of protein was measured using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). TG levels were measured based on an enzymatic assay from a method adapted for 96-well plates according to the manufacturer's instructions (Pulilai Bioengineering Institute).
Oil Red O staining
Cultured cells were fixed with 4% paraformaldehyde (in PBS) for 30 min and stained with 1% Oil Red O for 2 h. The stained sections were observed with an Olympus microscope and examined by a pathologist in a blinded manner.
Real-time polymerase chain reaction
Analyses on gene transcript levels were conducted by quantitative real-time polymerase chain reaction (PCR) method. After washing HepG2 cells twice with PBS, total mRNA was extracted using a standard TRIzol RNA isolation method [7] after stimulation as described above. The concentration and purity of total RNA were measured using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA 
Western blotting analysis
Proteins were extracted from HepG2 cells which were cultured in 25 cm-bottom-surface bottle. Cells were washed by 4°C PBS for 2 times firstly. Then, cells were added with 1 ml RIPA and 10 μl PMSF. The cells were collected with a cell scraper blow gently, after which in a centrifuge tube. Up steps were operated on ice.
Clumps of cells were placed in 4000 ×g centrifugation at 4°C for 30 min. Supernatant of 800 μl mixture was kept at −80°C. The concentration of protein was measured using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Proteins were mixed with sodium dodecyl sulfate (SDS)-loading buffer and boiled for 10 min. Then, protein samples were separated using 10% SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride membrane, and blocked with nonfat dry milk for 2 h at 37°C. Then, membranes were probed with antibodies (primary antibodies against SCD-1, ACC, IRE-1, p-IRE-1, XBP-1s, FAS, XBP-1u, PERK, p-eIF-2α, eIF-2α, and β-actin) overnight at 4°C. Subsequently, membranes were rinsed three times with TBST, after which they were incubated with secondary antibodies at room temperature for 2 h. After incubation, membranes were washed three times with TBST and followed by detection with electrochemiluminescence method. And, β-actin was used as an internal control.
Statistical analysis
All data are represented as the mean ± standard deviation (SD) and were analyzed. Two-tailed unpaired Student's t-tests were used for between-group comparisons. The analysis of variance multiple comparison test (SPSS 11.0, SPSS Inc., Chicago, IL, USA) followed by Tukey's post hoc test was used for comparisons among groups. A value of P < 0.05 was considered statistically significant.
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Effects of fructose on de novo lipogenesis in HepG2 cells
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Effects of tauroursodeoxycholic acid and thapsigargin on lipogenesis
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Effects of spliced X-box binding protein-1 overexpression on lipid synthesis in HepG2 cells
To further investigate the causal relationship between XBP-1 and de novo lipogenesis, active XBP-1s was overexpressed by transfection with a XBP-1s vector. As shown by Western blotting analysis [ Figure 5a ], XBP-1s protein expression was induced after transfection for 8 h 
dIscussIon
Chronic fructose consumption is considered as a contributing factor in the development of NAFLD. [31] There is now a great interest in the mechanism by which high fructose induces fatty liver. Acquired and accumulated excessive TGs in hepatocytes may be considered as the first step of the "two hits" in the progression of NAFLD. [32] Although considerable progress has been made in understanding the molecular mechanisms underlying hepatic steatosis, [33] satisfactory treatment modalities remain limited. The liver is the predominant organ in the body delegated to de novo lipogenesis. This process, in which fatty acids are newly synthesized from acetyl coenzyme A (converted from glucose through the tricarboxylic acid cycle), usually contributes about one-third of all TG in hepatocytes, but this contribution increases by approximately 6-fold in the abnormal state. [34] Two key transcription factors, SREBP-1c and ChREBP, and three key target enzymes, ACC, FAS, and SCD-1, participate in the lipogenesis process. In the present study, by determining TG levels and by histologic analysis, we demonstrated that fructose increased lipid accumulation in HepG2 cells in a dose-dependent manner. This study also demonstrated that factors associated with de novo TG synthesis (i.e., ACC, FAS, SCD-1, SREBP-1c, and ChREBP) were increased in HepG2 cells incubated with high fructose (20 mmol/L), compared with those incubated with PA (a saturated free fatty acid). Consequently, the findings suggest that chronic intake of fructose induces lipid accumulation through lipogenesis.
The UPR is an adaptive signaling pathway triggered in response to perturbations in ER homeostasis, conditions referred to as ERS. [13, 19] Recent animal and human studies have revealed on the one hand that obesity and fatty liver are associated with ERS-associated factors [21, 35, 36] and that these diseases can be attenuated by chemical chaperone 4-phenylbutyric acid, Schisandra chinensis extract, or gastric bypass surgery. [21, 37, 38] On the other hand, lipotoxic stress leads to ERS activation in the liver, [4] so the causal relationship -1c and ChREBP were significantly lower in F+ TUDCA group compared to F group and were significantly increased in Tg group compared to N group (n = 6), *P < 0.05 versus N group, † P < 0.05 versus F group. (c) Oil Red O straining was alleviated in F+ TUDCA group compared to F group and was sharpened in Tg group compared to N group. Scale bar = 50 μm. (d) Protein levels of three key enzymes (SCD-1, FAS, and ACC) were upregulated in F group compared to N group but were suppressed by TUDCA. They were significantly increased in Tg group compared to N group (n = 3), *P < 0.05 versus N group, † P < 0.05 versus F group. (e) Protein expression of p-IRE-1/IRE-1 and XBP-1s were significantly increased in HepG2 cells in F group compared to N group. They were lower in F+ TUDCA group compared to F group, but increased in Tg group (n = 3), *P < 0.05 versus N group, between ERS and lipogenesis remains to be clarified. Whereas these previous studies were based on human and animal experiments, the present study examined the role of ERS in lipogenesis at a cellular level. To investigate the role of ERS in fructose-induced lipogenesis, we first tested whether the putative chemical chaperone TUDCA (an ERS inhibitor) [20] this study provides evidence for a direct effect of ERS on lipogenesis. On this basis, we speculate that there may be a positive feedback loop between ERS and lipogenesis, and therefore that reducing ERS is a key to reducing lipogenesis and reversing NAFLD.
IRE1/XBP-1 is one of the three classic ERS pathways associated with growth, differentiation, and cellular apoptosis. [13] Recent studies in animals and cells have shed light on the role of XBP-1 in numerous diseases, such as obesity, insulin resistance, and metabolic syndrome.
[39]
XBP-1 protein expression in mice was elevated after mice were fed carbohydrates, and deletion of XBP-1 resulted in marked hypocholesterolemia and hypotriglyceridemia. [30] Fatty liver induced by a high-calorie diet could be protected against by decreasing XBP-1.
[12] The 3T3-L1 cells with XBP1 or IRE1α knockdown and XBP1-deficient mouse embryonic fibroblasts showed significantly weakened adipogenesis. [40] Further studies showed that selectively knocking down the XBP1 gene in the liver decreased critical genes involved in fatty acid synthesis. [30] Our study showed that in the presence of high fructose (20 mmol/L), there was significant upregulation of XBP-1s (active form) and downregulation of XBP-1u (inactive form). To elucidate the underlying mechanisms, we investigated hepatic regulation of TG synthesis by activating XBP-1. XBP-1s overexpression increased cellular TG accumulation, which was accompanied by increased mRNA expression of SREBP-1c and protein content of three key target enzymes associated with lipogenesis, ACC, FAS, and SCD-1, but not by a change in ChREBP mRNA expression. Again, silencing of XBP-1s expression effectively prevented against the lipid deposition in HepG2 cells induced by high fructose, by decreasing the transcriptional expression of de novo lipogenesis genes to alleviate further lipotoxic stress. Therefore, we explored the causal relationship between XBP-1s and lipid accumulation and found that high fructose-induced cellular lipid deposition in NAFLD was partially regulated by XBP-1s.
SREBP-1c and ChREBP are mediators of the transcriptional effects of lipogenic enzyme genes. Lipogenic genes such as FAS, ACC, and SCD-1 are activated by both SREBP-1c and ChREBP. SREBP-1c mainly targets glucokinase, the first enzyme of the glycolytic pathway, as well as FAS and ACC. [41] SREBPs are synthesized as inactive precursors bound to the membranes of the ER and thus must undergo proteolytic cleavage to liberate their N-terminal domain, which constitutes the mature transcription factor. ERS could induce cleavage of the precursor form of SREBP-1c (increasing the expression of the mature form of SREBP-1c in the nucleus) and expression of SREBP-1c target genes independent of insulin, but the role of XBP-1 is unclear. [42] Lee et al.'s research shows that the genetic deletion of XBP-1 in liver leads to a decrease in de novo lipid synthesis. [30] Our research indicates that XBP-1 is associated with SREBP-1c without ChREBP, but further experiment need to be done to research the exact mechanism. However, our study convinced that the high fructose accelerates ERS to enhance de novo lipogenesis.
Our study had several limitations. First, we investigated the effect of XBP-1 on lipogenesis in vitro; rodent experiments are needed to verify our results in vivo. Second, ERS includes three pathways, and research has shown that transcription factor-4 activation contributes to lipid accumulation; thus, XBP-1 may be only partially responsible for ERS aggravation.
The present study provides novel insight into the mechanisms involved in fructose-mediated hepatic hypertriglyceridemia and identifies ERS as a potential therapeutic target for NAFLD. Furthermore, we show that XBP-1 plays a critical role in de novo lipogenesis during NAFLD.
To sum up, exposure of HepG2 cells to fructose resulted in increased hepatic lipid deposition via acceleration of de novo lipogenesis compared with PA exposure. In addition, the findings suggest that XBP-1 is crucial for lipid synthesis. Thus, using compounds that selectively target XBP-1 may be beneficial in the treatment of NAFLD. 
背景：高果糖易导致肝脏的脂质沉积，其中20-30%的甘油三酯来源于脂质从头合成。有的研究证实内质网应激(Endoplasmic
